Cargando…
Engineering and combining oncolytic measles virus for cancer therapy
Cancer immunotherapy using tumor-selective, oncolytic viruses is an emerging therapeutic option for solid and hematologic malignancies. A considerable variety of viruses ranging from small picornaviruses to large poxviruses are currently being investigated as potential candidates. In the early days...
Autores principales: | Leber, Mathias F., Neault, Serge, Jirovec, Elise, Barkley, Russell, Said, Aida, Bell, John C., Ungerechts, Guy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7333629/ https://www.ncbi.nlm.nih.gov/pubmed/32718830 http://dx.doi.org/10.1016/j.cytogfr.2020.07.005 |
Ejemplares similares
-
Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021) -
Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
por: Leber, Mathias Felix, et al.
Publicado: (2018) -
Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023) -
MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021) -
Viro-antibody therapy: engineering oncolytic viruses for genetic delivery of diverse antibody-based biotherapeutics
por: Kontermann, Roland E., et al.
Publicado: (2021)